On the Company completed a confidentially marketed public offering through the issuance of common shares at a price of per share for gross proceeds of million and net proceeds of approximately million (approximately million net of share issue costs). Costs associated with the proceeds consisted of a cash commissions and share issue costs, which consisted of agent commission, legal and professional fees and listing fees.

 

 

On the Company entered into the Aspire Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of million of Common Shares over approximately months. The Purchase Agreement limits the amount of Aptose’s common shares that Aspire can own at time to of the issued and outstanding common shares of the Company, and limits the maximum number of common shares that can be issued under the Agreement to of the Company’s outstanding common shares on the date of the Purchase Agreement unless shareholder approval is obtained or the shares issued to date once the threshold is reached have an average purchase price equal to or exceeding Pursuant to the terms of this agreement, on the Company issued Common Shares (“Commitment Shares”) to Aspire Capital in consideration for entering into the Aspire Purchase Agreement. The Company recorded thousand in general and administrative expenses related to the issuance of the Commitment Shares. As at the Company had issued any shares under the Aspire Purchase Agreement, other than the Commitment Shares.

 

 

On the Company entered into the Aspire Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of million of Common Shares over approximately months. Pursuant to the terms of this agreement, on the Company issued Common Shares (“Commitment Shares”) to Aspire Capital in consideration for entering into the Aspire Purchase Agreement. The Company recorded thousand in general and administrative expenses related to the issuance of the Commitment Shares. During the period from up to the date the Aspire Purchase Agreement was terminated, the Company issued common shares under the agreement at an average price of per share for gross and net proceeds of million. On a cumulative basis up to the Company raised a total of approximately million gross and net proceeds under the Aspire Purchase Agreement. As of the Company has issued the maximum number of shares issuable under this facility without shareholder approval.

 

 

On the Company entered into the Aspire Purchase Agreement, which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of of Common Shares over approximately months. During the year ended and pursuant to the terms of the Aspire Purchase Agreement, Aspire Capital purchased Common Shares for gross proceeds of thousand ( thousand net of cash share issue costs) and the Company also issued Common Shares to Aspire Capital in consideration for entering into the Aspire Purchase Agreement.

 

During the months ended the Company issued common shares under the Aspire Purchase Agreement at an average price of per share for gross and net proceeds of approximately million. On a cumulative basis to the Company has raised a total of million gross proceeds under the Aspire Purchase Agreement, the total amount that was available under the Agreement.

 

 

On the Company entered into an “At-The-Market” Facility (“ATM”) equity distribution agreement with Piper Jaffray and Canaccord Genuity acting as co-agents. Under the terms of this facility, the Company from time to time, sell shares of our common stock having an aggregate offering value of up to million through Piper Jaffray and Cannacord Gennuity on the Nasdaq Capital Market. During the months ended the Company did issue any shares under this ATM equity.

  

 

On the Company entered into an “At-The-Market” Facility (“ATM”) equity distribution agreement with Cantor Fitzgerald acting as sole agent. Under the terms of this facility, the Company from time to time, sell shares of our common stock having an aggregate offering value of up to million through Cantor Fitzgerald on the Nasdaq Capital Market. During the months ended the Company issued shares under this ATM equity facility at an average price of for gross proceeds of thousand ( thousand net of share issue costs). During the months ended the Company issued shares under this ATM equity facility at an average price of for gross proceeds of million ( million net of share issue costs). Costs associated with the proceeds consisted of a cash commission. On a cumulative basis to the Company has raised a total of million gross proceeds ( million net of share issue costs) under the ATM Facility. The Company terminated this agreement on

 

 

Loss per common share is calculated using the weighted average number of common shares outstanding and is presented in the table below:

 

		Three months ended September 30,								Nine months ended September 30,
(in thousands)		2019				2018				2019				2018
Net loss		$	(6,844	)		$	(5,531	)		$	(18,568	)		$	(22,607	)
Weighted-average common shares – basic and diluted			55,454				34,587				47,315				32,039
Net loss per share – basic and diluted		$	(0.12	)		$	(0.16	)		$	(0.39	)		$	(0.71	)

 

The effect of any potential exercise of the Company’s stock options outstanding during the and month periods ended and has been excluded from the calculation of diluted loss per common share as it would be anti-dilutive.